Pulmonx Corporation - LUNG Company profit before taxes, interest and amortization
Pulmonx Corporation (LUNG) is highly valued by global physicians for the reliability of its Zephyr systems. EBITDA volatility illustrates the issuer's financial stability, where 0.00 captures the magnitude of this parameter. The business relies on a closed ecosystem of software and valves, which complicates the transition of clinics to other providers. Company revenues are based on equipment sales and the regular distribution of high-cost disposable components.
Summary analytical data breakdowns for Pulmonx (LUNG)
- market price and analyst price targets:
- issuer market value details:
- issuer book value statistics:
- business debt structure and liquidity details:
All Debt to Shareholders' Equity Ratio Pulmonx Corporation|LUNG - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio Pulmonx Corp|LUNG - Company Aggregate Debts|Debts to Book Value Pulmonx|LUNG - Company Long-Term Debts|Company Short-Term Indebtedness Pulmonx|Interim Coverage Ratio pulmonx.com
- company profitability and valuation multiples indicators:
LUNG - Net Profit|Future Profit Pulmonx Corporation|LUNG - P/E Multiple|Forward P/E Multiple Pulmonx Corp|LUNG - Price/Earnings to Growth Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Pulmonx|LUNG - Operating profit before deduction of amortization|Earnings per share for the trailing year Pulmonx|LUNG - Net earnings per share (EPS TTM)|Earnings per share growth in annualized terms for the last twelve months pulmonx.com|LUNG - Earnings per share growth in current year|Net earnings per one share growth forecast for next year Pulmonx Corporation
- sales revenue and business income indicators:
Summary company analytics:Pulmonx Corporation
This indicator measures actual cash flow from core operations, completely excluding GAAP/Non-GAAP accounting manipulations to reveal true operational efficiency. An analysis of cash operating profit before deductions allows for an assessment of how the expansion of Zephyr valves and the broadening of insurance coverage for Pulmonx Corporation (LUNG) convert into actual liquidity, minimizing the risk of overpaying for the asset between quarterly reports.
Who Pulmonx Corporation competes with
Operating profit EBITDA Dexcom CGM DXCM|PEN: Operating profit before deduction of amortization|novanta.com - Company profit before taxes, interest and amortization|HAE: Operating profit EBITDA|INSP - Operating income before deduction of amortization|PRCT (PROCEPT BioRobotics Inc) - Operating profit EBITDA|Operating profit before deduction of amortization CONMED Inc. (CNMD)|Operating profit before deduction of amortization PLSE (Pulse Biosciences, Inc.)|INMD (inmodemd.com) - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Picard Medical PMI|SRDX - Operating profit before deduction of amortization|Eversense - Operating profit EBITDA|Profit before interest, taxes and amortization NeuroPace Medical|TCMD: Operating profit EBITDA|Operating profit before amortization SNWV|OM (Outset Medical) - Operating profit EBITDA|Electromed Inc (ELMD) - Operating income before deduction of amortization|Operating profit EBITDA LNSR|Operating profit before deduction of amortization AVITA Medical Inc RCEL|Operating profit EBITDA PROF (Profound Medical)|Operating profit EBITDA Baird Medical Investment Holdings BDMD|EDAP - Profit before payment of interest, taxes and amortization|APYX: Profit before payment of interest, taxes and amortization|ICCM (icecure-medical.com) - Operating profit before deduction of amortization|TELA Bio - Income before deduction of interest, taxes and amortization|CTSO (CytoSorbents Corp) - Operating profit EBITDA|Profit before interest, taxes and amortization sensushealthcare.com SRTS|Profit before payment of interest, taxes and amortization Zynex (ZYXI)|electrocore.com (ECOR) - Operating profit before depreciation charges|Vicarious Surgical - Operating profit before deduction of amortization|Operating profit EBITDA Inspira Technologies Oxy B.H.N. Ltd. IINN|SeaStar Medical Holding - Operating profit EBITDA|Operating income before deduction of amortization IRIDEX Corporation IRIX|ibs.inc (INBS) - Profit before payment of interest, taxes and amortization|Profit before deduction of interest, taxes, depreciation and amortization XAIR (Beyond Air)|Profit before payment of interest, taxes and amortization Profusa, Inc.|Operating profit before deduction of amortization STRATA Skin (SSKN)|Operating profit EBITDA GCTK|NAOV - Profit before interest, taxes and amortization|Profit before payment of interest, taxes and amortization Venus Concept VERO|NUWE: Operating profit before amortization|AEMD: Operating profit before deduction of amortization|Asensus Surgical, Inc. - Company profit before taxes, interest and amortization|Avinger, Inc. (AVGR) - Profit before payment of interest, taxes and amortization|Profit before deduction of interest, taxes, depreciation and amortization BSGM (BioSig Technologies Inc.)|Operating profit before deduction of amortization CUTR|Operating profit EBITDA Know Labs Inc|Profit before payment of interest, taxes and amortization Inari (NARI)|Profit before payment of interest, taxes and amortization NVRO (Nevro Medical)|Profit before payment of interest, taxes and amortization ReShape Lifesciences Inc. RSLS|SILK - Operating profit before deduction of amortization
